Add Formweb to your mobile device
Search results for:
tocilizumab
tocilizumab
Brand names: Actemra
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, INTRAVENOUS | 20 mg/mL | Restricted |
Last updated: Nov. 17, 2023
- Black Box Warning: Serious infections risk
- Do Not Tube-LALK
- Restricted: tocilizumab (Actemra) is restricted to use in the Outpatient setting
Tocilizumab Executive Summary
***Tocilizumab (Actemra) is temporarily approved for use in cytokine storm related to COVID-19. Please reach out to Pharmacy Leadership for acquisition. See COVID-19 Treatment Recommendations for dosing.